Study towards improving artemisinin-based combination therapies-Reference-Cited by-同舟云学术

Study towards improving artemisinin-based combination therapies

Published:2021 Issue: Volume: Page:
ISSN:0265-0568
Container-title:Natural Product Reports
language:en
Short-container-title:Nat. Prod. Rep.

Author:

Lyu Hai-Ning¹²³⁴⁵^ORCID,Ma Nan¹²³⁴⁵^ORCID,Meng Yuqing¹²³⁴⁵,Zhang Xing¹²³⁴⁵,Wong Yin-Kwan¹²³⁴⁵,Xu Chengchao¹²³⁴⁵,Liao Fulong¹²³⁴⁵,Jiang Tingliang¹²³⁴⁵,Tu Youyou¹²³⁴⁵^ORCID,Wang Jigang¹²³⁴⁵

Affiliation:

1. Artemisinin Research Center

2. Institute of Chinese Materia Medica

3. China Academy of Chinese Medical Sciences

4. Beijing

5. China

Abstract

This highlight provides a brief history of artemisinin in its journey from being a natural product to drug, as well as the continuous efforts to improve ACTs with better efficacy against the parasites, which have prolonged life cycles.

Funder

National Natural Science Foundation of China

China Academy of Chinese Medical Sciences

National Science and Technology Program during the Twelfth Five-year Plan Period

National Basic Research Program of China

Publisher

Royal Society of Chemistry (RSC)

Subject

Organic Chemistry,Drug Discovery,Biochemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2021/NP/D0NP00079E

Reference46 articles.